Ann: Zantrene highly effective in EMD AML Mouse Model, page-98

Good news is that shorts are indeed starting to drop off now, good money has been made shorting this back to $1 to $2 range (despite cheerleaders telling you otherwise) but that means the chance of any kind of squeeze is now pretty remote.


The bearish engulfing for last month is not a positive indicator!

I suspect this could continue to slide back to sub $1. News flow is very minor in nature. They either needs a massive trial outcome now or a big ass director buy up to bring the buyers back and stymie the profit takers.

Anyway, GL to all. Buying over the longer term still looks OK, but it's a falling knife at the moment and it will take some time to turn sentiment around and see profits on any current buy.